×
Dr. Rizgar A. Mageed, PhD, FRCPath, FRCP

Dr. Rizgar A. Mageed has been a Professor of Experimental Immunology at the William Harvey Research Institute, St Bartholomew’s and the Royal London School of Medicine and Dentistry, Queen Mary University of London since 2003. Professor Mageed graduated from Baghdad University. He was awarded a PhD in Immunology from the Royal London Hospital Medical School, Division of Medicine at London University in 1985. He was appointed Research Fellow at the Department of Immunology, University of Birmingham Medical School in 1984 where he worked until 1990 and then joined the Kennedy Institute of Rheumatology, Imperial College-London as a Senior Scientist. In 1996, Professor Mageed was appointed Senior Lecturer at Imperial College-London. Between September 1997 and September 1998, he was a Welcome Trust Visiting Professor at the Department of Immunology and Microbiology at Stanford University School of Medicine, Stanford, California, USA. In 2000, Professor Mageed was awarded an Arthritis Research-UK Fellowship and appointed Senior Lecturer at the Center for Rheumatology at University College London (UCL). Professor Mageed was made Professor of Experimental Immunology in December 2002 and officially joined Queen Mary University of London in May 2003. In 2009 Professor Mageed became a Fellow of the Royal College of Pathologists (FRCPath) and in 2014 was awarded an Honorary Fellowship by the Royal College of Physicians (FRCP) in the United Kingdom. Professor Mageed is an internationally-recognized Principal Investigator in autoimmunity and an expert in the cellular, molecular and genetic aspects of autoimmune rheumatic diseases with a major focus on B lymphocytes. He is the author and joint author of and contributor to over 220 Journal Articles, Book Chapters and Conference Presentations in Immunology and Autoimmunity. Professor Mageed is a member of the British Society for Immunology (BSI) and the American Association of Immunologists (AAI). He serves as a member of the Trustees Committee of the American University of Iraq in Sulaimania. Since 2015 Professor Rizgar has also been country director of MDC-MedLabs medical laboratories operations in Iraq where he oversees the implementation of MDC-MedLabs laboratory business and scientific excellence in the region.